rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Todd C. Peterson

Director

Company insider

Files Form 4 as: Director, Armata Pharmaceuticals.

In numbers

Trades disclosed
10
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
10 Oct 2019
Last trade
9 Mar 2026
Last filed
11 Mar 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ARMP Armata PharmaceuticalsDirector · Biotechnology · last 9 Mar 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
9 Mar 2026filed 11 Mar 2026ARMP Armata Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—25,640 at $0.00filing
9 Mar 2026filed 11 Mar 2026ARMP Armata Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—25,640 at $0.00filing
5 Feb 2025filed 7 Feb 2025ARMP Armata Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—54,343 at $0.00filing
14 Mar 2024filed 18 Mar 2024ARMP Armata Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—39,666 at $0.00filing
14 Mar 2024filed 18 Mar 2024ARMP Armata Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—54,343 at $0.00filing
21 Dec 2023filed 26 Dec 2023ARMP Armata Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—10,461 at $0.00filing
13 Apr 2022filed 15 Apr 2022ARMP Armata Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—33,000 at $0.00filing
7 Jun 2021filed 9 Jun 2021ARMP Armata Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—28,000 at $0.00filing
8 Dec 2020filed 9 Dec 2020ARMP Armata Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—23,000 at $0.00filing
10 Oct 2019filed 15 Oct 2019ARMP Armata Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—27,383 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Deborah BirxChief Executive Officer · Chief Executive Officer at Armata Pharmaceuticals, filing Form 4 there in the last year
Daniel B. GilmerDirector · Director at Armata Pharmaceuticals, filing Form 4 there in the last year
Pierre KymeChief Business Officer · Chief Business Officer at Armata Pharmaceuticals, filing Form 4 there in the last year
Sarah J. SchlesingerDirector · Director at Armata Pharmaceuticals, filing Form 4 there in the last year
Joseph M. PattiDirector · Director at Armata Pharmaceuticals, filing Form 4 there in the last year